August 2019 - Saturn Partners

Knopp Biosciences Announces Start of Phase 2 Clinical Trial Evaluating Oral Dexpramipexole in Moderate-to-Severe Eosinophilic Asthma

Posted on August 20, 2019 at 10:58 am.

Knopp Biosciences LLC today announced the start of Phase 2 dose-ranging clinical trial in moderate-to-severe eosinophilic asthma. Recruitment in the trial is underway and the first patient has been enrolled. Click to View Article

The top three fastest growing fintech firms in the US

Posted on August 20, 2019 at 10:57 am.

Written by saturnadmin

Founded in 2015, YieldStreet is a New York-based fintech startup aimed at democratising investment opportunities in non-traditional markets like real estate, marine/shipping, legal finance, commercial loans and more. Click to View Article

Monthly Archives: August 2019